Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Terbinafine products are in shortage in Canada (4 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An antifungal used to treat fungal infections of the nails and skin.
Products affected
4 / 10
In shortage since
Sep 15, 2016
Reports on file
48
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TERBINAFINE
250MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02385279 · since Dec 14, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TERBINAFINE
250MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02385279 · since Dec 14, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TERBINAFINE
250MG · TABLET · SANIS HEALTH INC
DIN 02353121 · since Oct 15, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-TERBINAFINE
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02357070 · since Sep 15, 2016, est. end Dec 31, 2020 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TERBINAFINE
250MG · TABLET · TEVA CANADA LIMITED
DIN 02240346 · since Oct 18, 2016, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-TERBINAFINE
250MG · TABLET · JAMP PHARMA CORPORATION
DIN 02357070 · since Sep 15, 2017, est. end Dec 31, 2020 · Disruption of the manufacture of the drug.
Resolved
APO-TERBINAFINE
250MG · TABLET · APOTEX INC
DIN 02239893 · ended Apr 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-TERBINAFINE
250MG · TABLET · APOTEX INC
DIN 02239893 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TERBINAFINE
250MG · TABLET · TEVA CANADA LIMITED
DIN 02254727
Resolved
ACT TERBINAFINE
250MG · TABLET · TEVA CANADA LIMITED
DIN 02254727 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
Resolved
ACT TERBINAFINE
250MG · TABLET · TEVA CANADA LIMITED
DIN 02254727 · ended Aug 28, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TERBINAFINE
250MG · TABLET · TEVA CANADA LIMITED
DIN 02254727
Showing 12 of 48 reports. All reports are on file with Health Canada.
What's happening
Terbinafine is currently affected by 4 active shortage reports filed with Health Canada by SIVEM PHARMACEUTICALS ULC, SANIS HEALTH INC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Terbinafine is classified under “ANTIFUNGALS FOR SYSTEMIC USE” (ATC D01BA).
Recent changes
No changes recorded yet.
Common questions
What is Terbinafine used for?
An antifungal used to treat fungal infections of the nails and skin.
When will Terbinafine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Terbinafine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.